Oncology Marketing Strategy for Hospitals in India
Last reviewed
Cancer care marketing in India is about trust, clarity and support, not persuasion. Patients and families arrive frightened, often with a diagnosis from elsewhere, and want a second opinion, a clear plan and help with cost. Lead with multidisciplinary teams, fast second-opinion pathways, navigator support and honest financial guidance.
Updated 29 October 2026: merged in our guide on how cancer patients and families search online and added sections on family-first intake, document-upload second opinions, regional language, tumour-board summaries, financial counselling and cohort reporting.
This article is part of the healthcare digital growth series, best read in order from the pillar.










Why oncology marketing is different
India recorded an estimated 15.7 lakh new cancer cases in 2025, and about 1 in 9 Indians is likely to develop cancer in their lifetime. Treatment spans months and several modalities, so the relationship is long. Many patients travel to cities for care, which makes digital first contact and remote second opinions central.
Oncology marketing: a playbook for Indian hospitals
2:05Cancer care marketing is about trust, clarity and support, not persuasion. Patients and families arrive frightened, often with a diagnosis from elsewhere, and want a second opinion, a clear plan and help with cost. This version is updated for the NMC's advertising guidelines of October 2026.
Read the transcript
Cancer care marketing is about trust, clarity and support, not persuasion. Patients and families arrive frightened, often with a diagnosis from elsewhere, and want a second opinion, a clear plan and help with cost. This version is updated for the NMC's advertising guidelines of October 2026.
India recorded an estimated fifteen point seven lakh new cancer cases in 2025. Treatment spans months, so the relationship is long, and many patients travel to cities for care.
A test result or biopsy leads to urgent searching about the cancer type and where to go. Families share reports and seek a second view, often remotely. Then they weigh the team, the plan, the cost and the distance from home.
A dedicated second-opinion pathway: upload reports, get a navigator call, receive a written view within a stated time. Tumour board and team pages that show the specialists who review each case. And navigators who support families through the journey.
Start with real questions. How does a tumour board work? What should you bring for a second opinion? And what does treatment cost, phase by phase?
The Drugs and Magic Remedies Act lists cancer, so no cure claims for any drug or remedy. Avoid survival statistics unless they are your own audited data, clearly explained. And under the NMC's guidelines of October 2026, patient stories cannot be used for promotion, even with consent.
Oncology is well covered under PM-JAY and most insurance, but long treatments can exceed limits. Clear estimates by phase and help with scheme paperwork are among the most valuable things a hospital can offer.
The full guide, with sources, is on gauravphogat.com. The link is in the description.
Key facts for oncology marketers
| Fact | Figure | Source |
|---|---|---|
| Estimated new cancer cases (2025) | 15.70 lakh | Rajya Sabha reply via ETV Bharat |
| Estimated cancer deaths (2025) | 8.69 lakh | Rajya Sabha reply via ETV Bharat |
| Lifetime risk of developing cancer | About 1 in 9 Indians | IJMR 2022 via PubMed |
| PM-JAY coverage | Medical, surgical and radiation oncology are covered specialties | NHA HBP 2.2 manual |
How patients decide
- Suspicion or diagnosis. A test result or biopsy leads to urgent searching about the cancer type and where to go.
- Second opinion. Families share reports and seek a second view, often remotely and from another city.
- Choosing a centre. They weigh the team, technology, travel, cost and insurance.
- Treatment. Surgery, chemotherapy and radiotherapy over months, with many touchpoints.
- Survivorship. Follow-up, screening of family members and support groups.
How cancer patients and families search online
The first time I looked properly at the search data for an oncology service line, I stopped trusting the funnel I had built for everything else. The queries were not “oncologist near me”. They were the words on a report: the histology term, the stage, the drug the local doctor mentioned, typed late at night from a city hundreds of kilometres away. Almost none were typed by the patient.
A diagnosis is usually given at a smaller hospital, a diagnostic centre or a GP clinic. That evening a son, a daughter-in-law or a brother in another city starts searching. The session runs for weeks, on several devices and from several cities. The family is already past the symptom stage, so content that explains what a symptom might mean is of no use to them. They want to know what happens next and whether you are the place for it.
Four kinds of query to plan for
- Clinical understanding. What the stage means and what the treatment options are.
- Practical. Cost, duration, whether chemotherapy needs admission, whether there is a day-care unit.
- Comparative. This hospital versus that one, this city versus the metro.
- Financial. Insurance, government schemes, whether the package is cashless.
A service line that only answers the first group has built content for the wrong moment.
The family is the customer, so build intake for them
The person who calls is rarely the person who will be treated. The caller has a report, not symptoms, may not know the patient’s date of birth, and needs to check with three people and an employer before booking. The contact-centre script has to be written for a relative holding a report, not a patient describing a symptom.
The CRM has to match. One patient can have several contacts, numbers, languages and cities, and the case changes hands: the son who found you hands over to the daughter who is a nurse, who hands over to the uncle who is paying. A CRM that holds one mobile number per lead loses the case at the first handover.
I made this mistake in the first version of an oncology intake. The form asked for the patient’s details and callers filled in their own, because it was the only way to complete it. Half the records were wrong at source and we did not notice for a quarter, because the calls still happened. The fix was not a smarter form. It was a form that asked first: who are you calling for?
Channels that matter most
- A dedicated second-opinion pathway: upload reports, get a call from a navigator, receive a written view within a stated time.
- Tumour board and team pages showing the specialists who review each case.
- Search ads for cancer type plus ‘treatment’ and city terms, sending to calm, informative pages with a navigator contact.
- WhatsApp navigator support with consent, for appointments, reports and financial counselling.
- Screening awareness content for breast, cervical and oral cancer, timed to awareness months.
Make document upload the front door for second opinions
Most oncology enquiries to a large hospital are second opinions in substance, whether or not they are labelled that way. So the primary action on the page is document upload, not the booking button: reports, scans, prescriptions and photos of handwritten notes, with a stated turnaround, a named reviewer or coordinator, and a plain-language reply on the next step and its cost before anyone is asked to travel.
Some hospitals gate this behind a consultation fee and a visit, and that works when their name is already the answer to the comparative query. For most, the second opinion is what earns the visit. Build the path as upload, response, teleconsultation, then travel, and measure each step. Build it as a visit-first funnel and you will see enquiries without admissions and blame the campaigns when the real problem is the front door.
Regional language is not translation
The searcher may search in English, but the patient and the paying relative often do not speak it comfortably. Once the talk turns to treatment, cost and consent, it moves to Telugu, Tamil, Kannada, Bengali, Hindi or Marathi. Families go to the hospital whose coordinator called back in their own language, even when another programme is stronger. Staff the languages of your catchment, not the languages of your city.
A translated clinical page reads like a textbook to a family in a district town. A page written for them, in their language, on what treatment involves, how long it takes, what it costs, where to stay and what schemes cover, ranks for what they type and gets read aloud to the patient. The same applies to reminders, estimate letters and discharge summaries: if they arrive in English to a family that speaks Odia, the care promise stops at the front door.
Turn the tumour board into something families can see
The multidisciplinary meeting where surgeons, medical and radiation oncologists, pathologists and radiologists agree a plan is the clinical core of a serious programme. Families rarely know it exists. What they see is one doctor saying something on Tuesday and another saying something slightly different on Thursday.
Making the board visible is a product decision. Tell the family their case will be reviewed by the whole team on a stated day, then send one written summary in their language: who reviewed it, what was recommended, what the options are and what each involves. That summary gets forwarded to the relative who is paying and to the referring doctor, who then refers again. The clinical content belongs to clinicians. Marketing owns that the document exists as a standard, arrives on time through a channel the family uses, and is logged in the CRM. Most hospitals have the meeting. Few have the product.
Content to publish first
Start with the questions patients and families actually ask. Each of these should open with a short, direct answer and be reviewed by a specialist before it goes live.
- How a tumour board works and why it matters
- What to bring for a cancer second opinion
- Understanding the cost of cancer treatment and how insurance and schemes help
- What to expect in the first week of chemotherapy, for families
- Questions to ask your oncology team
- Caring for a family member during treatment
In my experience the practical pages (treatment duration, cost ranges, day care, accommodation, schemes) outperform the clinical ones in every language, and nobody in a marketing team wants to write them because they are not glamorous. Write them in the top three regional languages of your catchment before you write another clinical page. Publish honest cost ranges too; when they are missing, families go to forums where the numbers are invented.
Compliance rules to know
- The Drugs and Magic Remedies Act, 1954 lists cancer and tumours: no ‘cure’ claims for any drug, supplement or remedy.
- Avoid survival or success statistics unless they are your own audited data, clearly explained and appropriately qualified.
- Patient stories in oncology need especially careful consent and should never imply that one outcome is typical.
These sit on top of the rules that apply to every specialty: the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, which remain in force after the NMC’s 2023 regulations were put in abeyance and treat soliciting patients as unethical; the CCPA’s 2022 guidelines on misleading advertisements; ASCI’s codes, including its 2025 rules for health influencers; and the DPDP Act, 2023 for every enquiry you collect. The regulation section of key statistics 2026 has the enforcement numbers, and DPDP notice and consent covers enquiry data.
Judgement calls above the legal floor
- Do not run lead forms on pages that explain what a stage means. A family reading about a prognosis is not a lead.
- Do not retarget someone who read about advanced disease with an offer.
- Do not build lookalike audiences from oncology enquiries. The data is too sensitive and the consent basis under the DPDP Act does not stretch that far.
- Do not publish patient stories that describe outcomes in a way that implies they are typical, even with consent.
Drug names need a written policy because families search them constantly. A page that explains what a drug is, how it is given and what it costs is useful and legitimate. A page that promotes a drug, or the hospital as the place to get it, is not. Medical affairs should sign off every page in this category against a written checklist, because an agency will not know where the line is, and the line moves.
Insurance and government schemes
Oncology is well covered under PM-JAY and most insurance policies, though long treatments can exceed limits. Financial counselling, clear estimates by treatment phase and help with scheme paperwork are some of the most valuable things a hospital can offer. Note that IRDAI standard exclusions still allow reconstruction after cancer surgery.
Treat financial counselling as a funnel step
Cost is the most searched question after the diagnosis itself, and it is where most oncology journeys stall. A family that cannot see a credible number assumes the worst and either delays or goes to a public institution. A family that gets an estimate, a list of what insurance and state or central schemes may cover, and a named counsellor to call, moves forward.
So give financial counselling an owner and a turnaround. The estimate should be a versioned document in the family’s language, sent on the channel they use and logged in the CRM. The counsellor should be reachable without going through the general contact centre, and TPA empanelment for the relevant packages should be visible on the site and on the estimate. These levers sit outside marketing’s usual remit, which is exactly why the journey breaks there when growth does not own the whole path.
What to measure
Judge marketing on outcomes the hospital can verify, not clicks. These are the numbers I would put on a monthly dashboard:
- Second-opinion requests and time to written response
- Second opinion to treatment conversion
- Navigator response time on WhatsApp and calls
- Treatment completion at the same centre
- Share of patients from outside the city or state
Report by cohort, not by campaign
Last-click attribution does not work in oncology. A family may touch you eleven times over five weeks across three cities before anyone books. Report enquiries opened in a month and what happened to them over the next ninety days: upload to response, response to teleconsultation, teleconsultation to first visit, first visit to treatment start, and where cases come from by distance and referring doctor.
Take that to the CFO as a pipeline, the way a sales function would. Cost per enquiry looks high against a general OPD benchmark. The value per converted case, the length of the treatment relationship and the referrals it brings back from the same district are what justify the line, and none of that shows in a monthly lead report. I have had to make this argument in budget reviews more than once, and it only holds if the CRM was built for cases rather than leads from the start.
Where to start: the order of operations
- Pull six months of search and enquiry data for the line and classify it by intent: clinical, practical, comparative, financial. Note which group has no content.
- Rebuild intake around “who are you calling for” and document upload, with several contacts per case and language and city recorded.
- Rewrite the contact-centre script for a relative holding a report, and staff the languages of your catchment.
- Agree the tumour-board summary as a standard document with the clinical lead: format, turnaround, language, channel. Log it in the CRM.
- Write the practical pages in the top three regional languages of the catchment before another clinical page.
- Put a written content policy through medical affairs: no outcome claims, no lead forms on prognosis pages, no retargeting, no audience building from oncology data.
- Make financial counselling a tracked step with a named owner and a versioned estimate.
- Report to the CFO by cohort over ninety days, with value per converted case and referral source, and stop reporting monthly lead cost for this line.
The common mistake
Marketing technology, such as a new machine, ahead of the team and the patient support. Families choose people and pathways; equipment is a supporting fact.
Questions people ask
Focus on facts patients need: the team, how cases are reviewed, the second-opinion process, support services and how costs are handled. Avoid cure claims, fear-based messaging and unverified survival statistics, and have clinicians review all content.
Many patients arrive with a diagnosis from elsewhere and want reassurance before starting treatment. A clear, fast and remote-friendly second-opinion process is often the first real contact with the hospital and the main route into treatment.
Yes. Medical, surgical and radiation oncology are covered specialties in PM-JAY’s health benefit packages, within the scheme’s annual family cover. Hospitals should help eligible families with paperwork and explain any costs outside the scheme.
Who you are calling for. Most callers are relatives, so a form that only asks for patient details gets filled with the caller’s own details and the records are wrong at source. Start with who the enquiry is for, then allow several contacts per case with language and city recorded.
With a written policy. Pages that explain what a drug is, how it is given and what it costs are useful and legitimate. Pages that promote a drug, or the hospital as the place to get it, are not. Medical affairs should sign off every page in this category against a written checklist.
By cohort, not by campaign. Track enquiries opened in a month over the next ninety days: upload to response, response to teleconsultation, teleconsultation to first visit and first visit to treatment start, plus where cases come from by distance and referring doctor.
Part of the specialty marketing strategies series. This guide covers marketing, patient communication and compliance; it is not clinical advice.
Related guides
- Digital marketing for doctors in India: a practical guide
- Healthcare marketing comparisons
- Treatment estimate and payer mix in the glossary
Sources
Read my takes first in Google Search

